Rinsho Shinkeigaku (Clinical Neurology)

Symposium 26

Seed, aggregation and propagation of abnormal proteins could explain neurodegeneration?

Shigeo Murayama, M.D., Ph.D.

Department of Neuropathology (the Brain Bank for Aging Research)

Braak proposed propagation staging paradigm of Lewy-related alpha-synucleinopathy, which starts from medulla oblongata and extends rostrally to neocortex. Since this propagation shares that of bovine spongiformic encephalopathy, alpha-synuclein-prionopathy hypothesis was presented and augumented by pathological reports of Lewy body pathology in fetal tansplants of midbrain to patients with Parkinson disease (PD). The prionopathy hypothesis expanded to include tau and TDP-43, is now receiving considerable attention world wide. Laterality of clinical symptoms can be explained with this hypothesis in PD, amyotrophic lateral sclerosis-TDP43, frontotemoral lobar degeneration-semantic dementia-TDP43 and tauopathy including corticobasal degeneration and argyrophilic grain dementia. Major cons of prionopathy hypothesis is how to explain cell to cell transmission of intracellular amyloid-like proteins. Several clinical and experimental data are now accumulated to answer this question. The difference in speed of spread between prion disease and neurodegenerative disease could be explained by aggregation size of abnormal proteins. The hypothesis could also explain glinoneuronal interaction, which is receiving another hot topic of neurodeneration. We propose that seed, aggregation propagation of abnormal protein should form one factor of clinical progression of neurodegenerative diseases and can be a therapeutic targets in future research.
Full Text of this Article in Japanese PDF (477K)

(CLINICA NEUROL, 51: 1097|1099, 2011)
key words: Tau, alpha-synuclein, TDP-43, prion, amyloid beta protein

(Received: 20-May-11)